Patent Enablement Lessons from Amgen Inc. v. Sanofi

The more a patent claims, the more it must enable. This video discusses the enablement requirement of 35 U.S.C.S. § 112(a) as it relates to biotechnology and specifically antibody claims, addressed by the Supreme Court in Amgen Inc. v. Sanofi, 143 S. Ct. 1243 (2023).

Watch now »

Related Content

• Amgen Patent Ruling's Impact Extends Beyond Life Sciences
  Gain insight from Law360 expert analysis on the impacts of Amgen Inc. v. Sanofi on the enablement requirement in various areas of technology including chemical, artificial intelligence, mechanical, and electrical inventions.

• Antibody Claims: Patent Eligibility and Written Description Issues
  Understand patent subject matter eligibility and written description and enablement requirements for antibody-based treatments in the pharmaceuticals market.

• Written Description Statements of Law
  Find support for litigation briefs and office action responses regarding whether claims satisfy the written description requirement from this practice note summarizing legal principles and supporting cases.

• Responding to Rejections under 35 U.S.C. § 112
  Review considerations for responding to a rejection of a patent application based on the requirements of 35 U.S.C. § 112(a), 112(b), or 112(f)

• Office Action Response Argument (Enablement and Written Description Under Section 112(a))
  Utilize this template to respond to an office action rejecting a patent application based on lack of enablement and written description.

• Section 112(a) Rejections Checklist
  Make sure your office action response addresses all the key arguments with this checklist.

Practical Guidance Updates  
Featuring the latest updates from your Practical Guidance account.    

• Practical Guidance Journal Third Edition 2023 features Generative AI cautions and benefits, new trends in lending, environmental law considerations, and insightful market intelligence.
• Listen Up! The Practical Guidance and Law 360 Podcasts Resource Kit features interviews with industry-leading attorneys on cutting edge issues in the law: NFTs, Cannabis, COVID-19, and more.
• Check out our Practical Guidance Author Center! Learn about the 2000+ leading attorney authors contributing to our 26 practice areas, and find out how you can Become a Practical Guidance Author. Practical Guidance is committed to amplifying diverse voices of attorneys across all differences, including gender and race.
• Legal Developments provide the latest updates and analyses of emerging topics impacting your practice area. Visit the Legal Developments page to see the latest topics, which also include breaking legal news and related Practical Guidance content.
• Document alerts allow you to stay current on legal developments that affect your practice. Find out how to set up your document alerts.      

PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB

Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+